![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Hanzhong Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Fenbendazole for veterinary use, Process 2, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-250 - Rev 02
This Chemical Type CEP, issued on April 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1208 associated with this CEP further emphasizes